Navigation Links
PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy
Date:2/3/2009

r the next year as we continue to work to develop additional innovative therapies for the muscular dystrophy community."

About DMD/BMD

Duchenne and Becker muscular dystrophy (DMD/BMD) are progressive muscle disorders that result in the loss of both muscle function and independence. DMD/BMD is perhaps the most prevalent form of the muscular dystrophies and is the most common lethal genetic disorder diagnosed during childhood today. Each year, approximately 20,000 children worldwide are born with DMD (one of every 3,500 male children). It is estimated that one in 10 DMD patients are likely to have a Becker presentation, a milder form of the disease that is associated with later manifestation of symptoms. Further information regarding DMD and BMD is available through the Muscular Dystrophy Association (www.mdausa.org), Parent Project Muscular Dystrophy (www.parentprojectmd.org) and the Association Francaise contre les Myopathies (www.afm-france.org).

About Ataluren (PTC124(TM))

Ataluren is an orally delivered, investigational new drug discovered by PTC Therapeutics. The drug is being developed as a new approach for the treatment of nonsense mutation genetic disorders. Nonsense mutations create a premature stop signal in the mRNA causing the ribosome to terminate translation before a full-length protein is generated. This causes the protein to be truncated and non-functioning. Ataluren is designed to allow the ribosome to continue translation of the mRNA, by overriding the premature stop signal leading to the formation of a functioning protein. Ataluren is a potential therapy for patients with nonsense mutation genetic disorders.

Ataluren has demonstrated proof of concept in Phase 2a clinical trials and is currently
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
2. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
3. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
4. Phico Therapeutics Receives GBP1 Million Award From the Wellcome Trust to Take Anti-MRSA Nasal Product Through Early Clinical Trials
5. Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
6. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
7. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
8. Cara Therapeutics Initiates Phase II Proof-Of-Concept Trial of Novel Analgesic in Acute Post-Operative Pain
9. ExonHit Therapeutics Expands Strategic Collaboration With Allergan
10. Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults
11. Synvista Therapeutics Announces First Dosing of SYI-2074 in Clinical Trial for Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013 /PRNewswire-iReach/ -- Specific Technologies, ... first study demonstrating detection of pathogenic bacteria, including ... and Bacillus anthracis which feature ... list of potential bio-threats. This seminal study, conducted ... Laboratory, Salisbury (DSTL), ...
(Date:5/20/2013)... Sequent Medical, Inc. announced today that it ... family of WEB ® Aneurysm Embolization Devices, and ... in select neurovascular centers in Europe.  The SL family ... enable physicians to treat a broader range of aneurysms ... are made possible by further advancement of Sequent Medical,s ...
(Date:5/20/2013)... , LONDON , ... May 20, 2013 Arthroscopy ... Osteoarthritis and Preference for Minimally Invasive Procedures to Drive ... and market trends for the six arthroscopy device market ... arthroscopy implants, arthroscopy radio frequency systems, and arthroscopy visualization ...
Breaking Medicine Technology:Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 4
... Cardiology publishes positive ATLAS clinical dataNATICK, Mass., Feb. ... BSX ) today announced that it has submitted ... the final modules of the Company,s Pre-Market Approval ... Paclitaxel-Eluting Coronary Stent System and its TAXUS Liberte ...
... 4 Here are highlights from the February issue ... cite this publication as often as you wish. ... is required. Reprinting is allowed for a fee. ... permit: Visit www.bookstore.mayoclinic.com or call toll-free for ...
Cached Medicine Technology:Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 2Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 3Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 4Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 5February 2009 Mayo Clinic Women's HealthSource Highlights Diabetes and Heart Disease, Going Vegetarian and Tinnitus 2February 2009 Mayo Clinic Women's HealthSource Highlights Diabetes and Heart Disease, Going Vegetarian and Tinnitus 3February 2009 Mayo Clinic Women's HealthSource Highlights Diabetes and Heart Disease, Going Vegetarian and Tinnitus 4February 2009 Mayo Clinic Women's HealthSource Highlights Diabetes and Heart Disease, Going Vegetarian and Tinnitus 5
(Date:5/20/2013)... San Diego, CA (PRWEB) May 20, 2013 ... country and around the world will make the pilgrimage ... for the 2nd annual Digital Health Summer Summit ... two-day conference provides a unique forum to showcase the ... lessons and best practices, and network with some of ...
(Date:5/20/2013)... Chicago, IL (PRWEB) May 20, 2013 ... of innovative cloud and on-premise business process ... version 6.0 of its next-generation integration solution. ... data integration solution that seamlessly automates business ... and reporting with meaningful business user interaction ...
(Date:5/20/2013)... 20 (HealthDay News) -- Although many hospital intensive ... staff to help improve outcomes, new research suggests ... Since one-third of teaching hospitals in the ... staff a nighttime physician in the ICU, the ... doctors away from hospitals with fewer resources, the ...
(Date:5/20/2013)... 20, 2013 In celebration of National ... scientific accomplishments achieved at The Feinstein Institute for ... scientists, Advancing Women in Science and Medicine (AWSM) ... 17. Scientists, educators, business and community leaders from ... achievements of women in science. , “Women face ...
(Date:5/20/2013)... about toothpaste that transforms the sweet flavor of orange ... that mysterious sensory phenomenon in colorful, animated detail ... Society,s award-winning Bytesize Science video series at ... largest scientific society, explains that the mainstay ingredients in ... SLS for short. When you brush your teeth, SLS ...
Breaking Medicine News(10 mins):Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 2Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 3Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 4Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 2Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 3Health News:Nighttime Docs at ICUs Don't Boost Patient Outcomes: Study 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3
... HOUSTON Regardless of an individual,s dietary and lifestyle ... deprived neighborhood may increase a person,s risk for death, ... Cancer Research Conference on Frontiers in Cancer Prevention Research, ... Diet and Health Study and found that people living ...
... M.D., Professor of Medicine at Case Western Reserve University ... Medical Center has been awarded a 10 year, $19.7M ... Prevention (CDC) as an international clinical trials site for ... is a partnership of U.S. and international clinical investigators ...
... , NEW YORK, Dec. ... report is available in its catalogue: , ... http://www.reportlinker.com/p0167257/Mesenchymal-Stem-Cells-Advances--Applications.html , Mesenchymal stem cells (MSCs) are ... of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic ...
... , , Through her ... of urological patient care , BALTIMORE, Dec. 8 ... its Executive Director Sandra Vassos was presented with the Star ... Star Breakfast in New York City. The Star Award recognizes ...
... ... to hip replacement surgery in patients 20 – 60 years of age. , ... (PRWEB) December 8, 2009 -- Dr. Einhorn’s ... offers patients a less invasive alternative to hip replacement., , ,Using non-embryonic stem cells harvested ...
... , CHARLOTTE, N.C., Dec. ... the Blue Cross and Blue Shield Association (BCBSA) as ... EPLS and USA PATRIOT Act compliance solutions. Under the contract, ... its member Blue Cross and Blue Shield companies nationwide. ...
Cached Medicine News:Health News:People living in poorer neighborhoods at increased risk for death, worse health risks 2Health News:Case Western Reserve to receive $19.7m to study tuberculosis treatment drugs 2Health News:Reportlinker Adds Mesenchymal Stem Cells, Advances & Applications 2Health News:Reportlinker Adds Mesenchymal Stem Cells, Advances & Applications 3Health News:Reportlinker Adds Mesenchymal Stem Cells, Advances & Applications 4Health News:New York Women's Agenda Presents AUA Foundation Executive Director Sandra Vassos with Star Award 2Health News:New York Women's Agenda Presents AUA Foundation Executive Director Sandra Vassos with Star Award 3Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 2Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 3Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 4Health News:The National Blue Cross and Blue Shield Association Selects ATTUS Technologies as Preferred Provider for OFAC, OIG, EPLS and USA PATRIOT Act Compliance 2Health News:The National Blue Cross and Blue Shield Association Selects ATTUS Technologies as Preferred Provider for OFAC, OIG, EPLS and USA PATRIOT Act Compliance 3
The Stryker Bioabsorbable Wedge Interference Screw is made of Poly-L Lactic Acid (PLLA). The patented wedge design makes it perfect for cruciate reconstruction and is indicated for BTB and soft tissu...
The Stryker Shoulder Instrumentation Set is ideal for open and arthroscopic shoulder procedures. The kit includes all the necessary tools for bone and tissue preparation as well as suture management ...
... Arthroscopy Scissor is ideal for excising soft tissue ... in the joint. The serrated edge on the ... as hold tissue within the jaws for more ... right jaw curvatures, are the perfect tools for ...
... The Series I Instrument program offers state-of-the-art ... profile, while maintaining strength and durability. Low ... in tight joint spaces. Series I instruments ... tip style, size and angle required for ...
Medicine Products: